BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26492625)

  • 1. Protection Against H7 Subtype Influenza Virus Infection in Mice by Passive Transfer of Neutralizing Monoclonal Antibody.
    Zhang Z; Liu M; Zheng S
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):360-5. PubMed ID: 26492625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
    Stadlbauer D; Amanat F; Strohmeier S; Nachbagauer R; Krammer F
    Emerg Microbes Infect; 2018 Jun; 7(1):110. PubMed ID: 29925896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans.
    Li M; Chen L; Wang Q; Hao M; Zhang X; Liu L; Yu X; Yang C; Xu J; Chen J; Gong R
    Antiviral Res; 2019 Oct; 170():104556. PubMed ID: 31299269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
    Tan GS; Leon PE; Albrecht RA; Margine I; Hirsh A; Bahl J; Krammer F
    PLoS Pathog; 2016 Apr; 12(4):e1005578. PubMed ID: 27081859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus.
    Yang F; Xiao Y; Lu R; Chen B; Liu F; Wang L; Yao H; Wu N; Wu H
    Emerg Microbes Infect; 2020; 9(1):664-675. PubMed ID: 32193996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.
    Wang J; Chen Z; Bao L; Zhang W; Xue Y; Pang X; Zhang X; Qin C; Jin Q
    J Virol; 2015 Sep; 89(17):9115-8. PubMed ID: 26063436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
    Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
    Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.
    Ito M; Yamayoshi S; Murakami K; Saito K; Motojima A; Nakaishi K; Kawaoka Y
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30754701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
    Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
    Nat Commun; 2024 May; 15(1):4505. PubMed ID: 38802413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
    Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
    Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice.
    Tang LH; Lim JH; Kuah LF; Lau YF
    Vaccine; 2014 Sep; 32(42):5375-8. PubMed ID: 25130540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.
    Pan W; Han L; Dong Z; Niu X; Li Z; Bao L; Li C; Luo Q; Yang Z; Li X; Huang J; Feng L; Qin C; Zhong N; Chen L
    Antiviral Res; 2014 Jul; 107():1-5. PubMed ID: 24746458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses.
    Wang H; Zhou J; Wang D; Huang B; Tan W
    Sci China Life Sci; 2020 Feb; 63(2):279-289. PubMed ID: 31147904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
    Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
    PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.